US$ 28.16
glp-1 receptor agonist type 1 diabetes trial liraglutide The role of GLP1 agonists in adult-onset mellitus New Developments in Pharmacological Treatment
Description
Long-acting GLP-1 receptor agonists improve glycemic control in type 2 diabetes patients while posing a low risk of hypoglycaemia due to their glucose-dependent mode of action

Rubino D, Abrahamsson N, Davies M, et al

This level of detail is beneficial for pinpointing changes

Who will hit a trillion-dollar valuation firstNovo or Lillyand why does obesity matter so much to investors
